Document Detail


Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe?
MedLine Citation:
PMID:  15215005     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Somatostatin and its analogs have recently been introduced in the treatment of chylous effusions in infants and children following surgery. The safety profile of this treatment in critically ill patients has not been fully evaluated. DESIGN: Retrospective case review. SETTING: Tertiary pediatric cardiac center. PATIENTS: A male infant born by cesarean section with a birth weight of 2.6 kg. INTERVENTIONS: None. CONCLUSIONS: We report the association of postoperative chylothorax treated with somatostatin analog (octreotide) and necrotizing enterocolitis in an infant following aortic coarctation repair.
Authors:
Hadi Mohseni-Bod; Duncan Macrae; Zdenek Slavik
Related Documents :
5895 - The evaluation of continuous fetal heart rate monitoring in high-risk pregnancy.
9512325 - Emergency hysterectomy in modern obstetric practice. changing clinical perspective in t...
10313505 - Vaginal birth after cesarean section in an hmo.
16380405 - Reduced enterobacterial and increased staphylococcal colonization of the infantile bowe...
1261045 - Congenital adrenal hyperplasia caused by defect in steroid 21-hydroxylase. establishmen...
22385055 - New pharmacological approaches in infants with hypoxic-ischemic encephalopathy.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies     Volume:  5     ISSN:  1529-7535     ISO Abbreviation:  Pediatr Crit Care Med     Publication Date:  2004 Jul 
Date Detail:
Created Date:  2004-06-24     Completed Date:  2004-10-07     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  100954653     Medline TA:  Pediatr Crit Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  356-7     Citation Subset:  IM    
Affiliation:
Paediatric Intensive Care Unit, Royal Brompton & Harefield NHS Trust, Royal Brompton Hospital, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aortic Coarctation / surgery
Cardiac Surgical Procedures / adverse effects*
Chylothorax / drug therapy*,  etiology
Gastrointestinal Agents / therapeutic use*
Humans
Infant, Newborn
Male
Octreotide / therapeutic use*
Postoperative Complications / drug therapy*
Chemical
Reg. No./Substance:
0/Gastrointestinal Agents; 83150-76-9/Octreotide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Factors contributing to successful discontinuation from inhaled nitric oxide therapy in pediatric pa...
Next Document:  Identifying children at high risk for psychological sequelae after pediatric intensive care unit hos...